Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylnaltrexone for prevention of intrathecal morphine-induced pruritus after caesarean delivery
ACTRN12612000572864Phase 4Completed
- Sponsor
- King Edward Memorial Hospital for Women
- Start
- Jun 2012
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 4, randomised, double-blind trial of methylnaltrexone in pruritus, sponsored by King Edward Memorial Hospital for Women. Primary endpoint: Severity of intrathecal morphine-induced pruritus. Started Jun 2012; status: completed.
02
Drugs
methylnaltrexone
03
Conditions
pruritus
Beyond the preview
Go deeper on ACTRN12612000572864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000572864.